SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001815776-24-000023
Filing Date
2024-03-25
Accepted
2024-03-25 20:36:10
Documents
1
Period of Report
2024-03-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1711413359.html 4  
1 FORM 4 wk-form4_1711413359.xml 4 4383
  Complete submission text file 0001815776-24-000023.txt   6058
Mailing Address C/O REGULUS THERAPEUTICS INC. 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address
Chevallard Daniel R. (Reporting) CIK: 0001706176 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40532 | Film No.: 24780692

Mailing Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014
Business Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014 858-925-7000
LENZ Therapeutics, Inc. (Issuer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)